Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 16, 2026 VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to […]

Hain Celestial Announces Fiscal 2026 Second Quarter Earnings Results Conference Call and Webcast GlobeNewswire January 16, 2026 HOBOKEN, N.J., Jan. 16, 2026 (GLOBE NEWSWIRE) — The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, will release its fiscal second quarter

Coherent Launches AxioView(TM) Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters GlobeNewswire January 16, 2026 SAXONBURG, Pa., Jan. 16, 2026 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of AxioView(TM) imaging fiber assemblies, designed for optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and multimodal catheter-based imaging

Arteris Announces New Employment Inducement Grants GlobeNewswire January 16, 2026 CAMPBELL, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the compensation committee of the company's board of directors has granted an aggregate of 477,208 restricted stock units

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 16, 2026 CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels

Avista files four-year rate plan in Washington to support reliable service and maintain critical infrastructure Proposal aims to deliver predictable costs while addressing grid upgrades, wildfire resiliency, and higher power supply expenses. GlobeNewswire January 16, 2026 SPOKANE, Wash., Jan. 16, 2026 (GLOBE NEWSWIRE) — Today Avista (NYSE: AVA) filed a four-year general rate case with

Oklahoma City, Ok, Jan. 16, 2026 (GLOBE NEWSWIRE) — Greta & Co Travel Design announces its next-generation luxury safari offerings for 2026, curated by acclaimed Virtuoso advisor Greta Meschke after an expansive journey through eight African countries. Drawing on deep local connections, industry recognition, and firsthand discovery, these new itineraries reflect a bold shift in

Award-Winning Virtuoso Advisor Unveils New Era of Luxury African Safaris for 2026 Insider Access, Transformative Experiences and Free Packing Guide for African Safari Travelers GlobeNewswire January 16, 2026 Oklahoma City, Ok, Jan. 16, 2026 (GLOBE NEWSWIRE) — Greta & Co Travel Design announces its next-generation luxury safari offerings for 2026, curated by acclaimed Virtuoso advisor

Sanmina Corporation (NASDAQ: SANM) announced today that it will host its first quarter fiscal 2026 earnings conference call on Monday, January 26, 2026 at 5:00 PM ET. The live webcast presentation and supporting materials will be available on the Sanmina website at www.sanmina.com in the Investor Relations section. A webcast replay will be available at

MetaVia Inc. (Nasdaq: MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the closing of its previously announced underwritten public offering of Class A Units and Class B Units for gross proceeds of approximately $9.3 million, prior to deducting underwriting discounts and commissions and offering expenses and excluding